| [1] | International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use (1996) ICH harmonized tripartite guideline:Guideline for Good Clinical Practice E6.
|
| [2] | Directive 2001/20/EC of the European Parliament and of the Council of 4 April 2001 on the approximation of the laws, regulations and administrative practice in the conduct of clinical trials on medicinal products for human use (2001) Official Journal of the European Communities L. 121: 34–44.
|
| [3] | Council for International Organizations of Medical Sciences (CIOMS) (2002) International ethical guidelines for biomedical research involving human subjects.
|
| [4] | Council of Europe (2005) Additional protocol to the convention on human rights and biomedicine, concerning biomedical research. European Treaty Series No.195.
|
| [5] | World Medical Association. Declaration of Helsinki: Ethical principles for medical research involving human subjects. Adopted June 1964, last amended October 2008. (After the submission of this manuscript, amended in October 2013.)
|
| [6] | Cardon PV, Dommel FW, Trumble PR (1976) Injuries to research subjects: A survey of investigators. N Engl J Med 295: 650–654.
|
| [7] | Zarafonetis CJ, Riley Jr PA, Willis 3rd PW, Power LH, Werbelow J, et al. (1978) Clinically significant adverse effects in a Phase 1 testing program. Clin Pharmacol Ther 24: 127–132.
|
| [8] | President's Commission for the Study of Ethical Problems in Medicine and Biomedical and Behavioral Research (1982) Compensating for research injuries: the ethical and legal implications of programs to redress injured subjects.
|
| [9] | Speirs CJ, Griffin JP (1983) A survey of the first year of operation of the new procedure affecting the conduct of clinical trials in the United Kingdom. Br J Clin Pharmacol 15: 649–655.
|
| [10] | Royle JM, Snell ES (1986) Medical research on normal volunteers. Br J Clin Pharmacol 21: 548–549.
|
| [11] | Resnik DB (2006) Compensation for research-related injuries. Ethical and legal issues. J Leg Med 27: 263–287.
|
| [12] | Watanabe H, Kageyama S, Kusuoka H, Ono S, Saito K, et al. (2011) Protection of human subjects and compensation for research-related injuries: Proposal of explanation sheet based on survey of the actual status in Japan. Rinsho Hyoka (Clin Eval) 39: 5–29 (Japanese)..
|
| [13] | Kurihara C (2011) Right to compensation of volunteers for research-related injuries: Comparative study and future perspective in view of global clinical trials. Rinsho Hyoka (Clin Eval) 39: 31–62 (Japanese)..
|
| [14] | Slack C, Singh P, Strode A, Essack Z (2012) Compensation for research-related injury in South Africa: A critique of the good clinical practice (GCP) guidelines. S Afr J BL 5: 91–94.
|
| [15] | Munshi R, Thatte U (2013) Compensation for research related injury. Perspectives in Clinical Research 4: 61–69.
|
| [16] | Gainotti S, Petrini C (2010) Insurance policies for clinical trials in the United States and in some European countries. J Clinic Res Bioeth 1: 101 doi: –10.4172/2155–9627. 1000101.
|
| [17] | Nabeoka Y (2012) Protection of human subjects and compensation for research-related injuries. PHARM STAGE 12: 26–34 (Japanese).
|
| [18] | Office for Drug-Induced Damages, Pharmaceutical and Food Safety Bureau, Ministry of Health, Labor and Welfare: 8th Study Committee on relief of the health damage caused by anti-cancer drugs, etc. Material #5: Overview of the compensation system for adverse drug reactions in foreign countries. (Japanese)
|
| [19] | Ministry of Health and Welfare Japan(1997) Ministerial Ordinance on Good Clinical Practice. (Japanese)
|
| [20] | Ministry of Health, Labour and Welfare Japan(2008) Ethical Guidelines for Clinical Research. (Japanese)
|
| [21] | Japanese Pharmaceutical Industry Legal & Business Affairs Association (2009) Guidelines on compensation for injury resulting from participation in clinical trials. Legal Mind Supplement 35: 6–20. (Japanese)
|
| [22] | Association of the British Pharmaceutical Industry (ABPI) (1991) Clinical trial compensation guidelines.
|
| [23] | Association of the British Pharmaceutical Industry (ABPI) (1988) Guidelines for medical experiments in non-patient human volunteers.
|
| [24] | The Association of the British Pharmaceutical Industry (ABPI) (2007) Guidelines for phase 1 clinical trials.
|
| [25] | The Association of the British Pharmaceutical Industry (ABPI), BioIndustry Association, Clinical Contract Research Association (2012) Insurance and compensation in the event of injury in Phase I clinical trials.
|
| [26] | Japanese Pharmaceutical Industry Legal & Business Affairs Association (2009) Result of questionnaire survey of compensation. Legal Mind Supplement 35: 60–118. (Japanese)
|
| [27] | Paasche-Orlow MK, Brancati FL (2005) Assessment of medical school institutional review board policies regarding compensation of subjects for research-related injury. Am J Med 118: 175–180.
|
| [28] | Thatte UM, Kulkarni-Munshi R, Kalekar SA (2009) Review of policies for injuries to research participants in India. J Med Ethics 35: 133–139.
|
| [29] | Bavdekar SB (2009) Informed consent documents submitted for initial review: What do they state about compensation for injured research participants? Indian J Med Sci 63: 455–460.
|
| [30] | Ministry of Health and Family Welfare, Government of India. The Drugs and Cosmetics (First Amendment) Rules (2013) Inserted Appendix XII-Compensation in case of injury or death during Clinical Trial, Rule 122-DAB. Clause (v) in Schedule Y, substitutes clause (iv) in Schedule Y.
|
| [31] | Medicines Australia (2004) Guidelines for compensation for injury resulting from participation in a company-sponsored clinical trial.
|
| [32] | The Researched Medicines Industry Association of New Zealand Inc. (2008) Researched medicine industry guidelines on clinical trials compensation for injury resulting from participation in an industry-sponsored clinical trial.
|
| [33] | Department of Health (2006) Guidelines for Good Practice in the Conduct of Clinical Trials with Human Participants in South Africa.
|
| [34] | Ministry of Health, Singapore (2007) National Medical Ethics Committee Guidelines. NMEC Recommendations on clinical trials: Update focusing on phase 1 trials.
|
| [35] | The National Commission for the Protection of Human Subjects of Biomedical and Behavioral Research, Office of the Secretary, U. S. Department of Health, Education, and Welfare (1979) The Belmont Report: Ethical Principles and Guidelines for the Protection of Human Subjects of Research.
|
